Soligenix, Inc. (SNGX) stock
SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.28−0.01 (-2.67%)
Close on Nov 17, 2026Market cap $6.11MP/E –Yield –
Soligenix enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Soligenix's enterprise value was -$2.86M on Nov 11, 2026, against $5.15M a year earlier. Over the last 5 years it ranged from -$8.88M to $14.92M, with a median of -$2.10M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$2.86M | -206.3% |
| 2025 | Dec 31, 2025 | $2.69M | – |
| 2024 | Dec 31, 2024 | -$3.65M | – |
| 2023 | Dec 29, 2023 | -$2.44M | -196.4% |
| 2022 | Dec 30, 2022 | $2.53M | – |
| 2021 | Dec 31, 2021 | -$719.98K | -102.7% |
| 2020 | Dec 31, 2020 | $27.02M | +40.9% |
| 2019 | Dec 31, 2019 | $19.17M | +449.9% |
| 2018 | Dec 31, 2018 | $3.49M | -57.2% |
| 2017 | Dec 29, 2017 | $8.15M | +191.8% |
| 2016 | Dec 30, 2016 | $2.79M | -89.5% |
| 2015 | Dec 31, 2015 | $26.55M | +52.6% |
| 2014 | Dec 31, 2014 | $17.40M | -37.6% |
| 2013 | Dec 31, 2013 | $27.89M | +830.4% |
| 2012 | Dec 31, 2012 | $3.00M | -97.6% |
| 2011 | Dec 30, 2011 | $125.37M | – |
See a number that looks wrong?